Literature DB >> 27562848

Extracellular Mitochondria and Mitochondrial Components Act as Damage-Associated Molecular Pattern Molecules in the Mouse Brain.

Heather M Wilkins1,2, Scott J Koppel1,2, Ian W Weidling2,3, Nairita Roy3, Lauren N Ryan2, John A Stanford3, Russell H Swerdlow4,5,6,7,8.   

Abstract

Mitochondria and mitochondrial debris are found in the brain's extracellular space, and extracellular mitochondrial components can act as damage associated molecular pattern (DAMP) molecules. To characterize the effects of potential mitochondrial DAMP molecules on neuroinflammation, we injected either isolated mitochondria or mitochondrial DNA (mtDNA) into hippocampi of C57BL/6 mice and seven days later measured markers of inflammation. Brains injected with whole mitochondria showed increased Tnfα and decreased Trem2 mRNA, increased GFAP protein, and increased NFκB phosphorylation. Some of these effects were also observed in brains injected with mtDNA (decreased Trem2 mRNA, increased GFAP protein, and increased NFκB phosphorylation), and mtDNA injection also caused several unique changes including increased CSF1R protein and AKT phosphorylation. To further establish the potential relevance of this response to Alzheimer's disease (AD), a brain disorder characterized by neurodegeneration, mitochondrial dysfunction, and neuroinflammation we also measured App mRNA, APP protein, and Aβ1-42 levels. We found mitochondria (but not mtDNA) injections increased these parameters. Our data show that in the mouse brain extracellular mitochondria and its components can induce neuroinflammation, extracellular mtDNA or mtDNA-associated proteins can contribute to this effect, and mitochondria derived-DAMP molecules can influence AD-associated biomarkers.

Entities:  

Keywords:  Alzheimer’s disease (AD); Amyloid precursor protein (APP); Damage associated molecular pattern (DAMP); Mitochondria; Mitochondrial DNA (mtDNA); Neuroinflammation

Mesh:

Substances:

Year:  2016        PMID: 27562848      PMCID: PMC5097888          DOI: 10.1007/s11481-016-9704-7

Source DB:  PubMed          Journal:  J Neuroimmune Pharmacol        ISSN: 1557-1890            Impact factor:   4.147


  27 in total

Review 1.  The nuclear factor kappa B signaling pathway: integrating metabolism with inflammation.

Authors:  Laura Tornatore; Anil K Thotakura; Jason Bennett; Marta Moretti; Guido Franzoso
Journal:  Trends Cell Biol       Date:  2012-09-18       Impact factor: 20.808

2.  R47H Variant of TREM2 Associated With Alzheimer Disease in a Large Late-Onset Family: Clinical, Genetic, and Neuropathological Study.

Authors:  Olena Korvatska; James B Leverenz; Suman Jayadev; Pamela McMillan; Irina Kurtz; Xindi Guo; Malia Rumbaugh; Mark Matsushita; Santhosh Girirajan; Michael O Dorschner; Kostantin Kiianitsa; Chang-En Yu; Zoran Brkanac; Gwenn A Garden; Wendy H Raskind; Thomas D Bird
Journal:  JAMA Neurol       Date:  2015-08       Impact factor: 18.302

3.  Mitochondrial lysates induce inflammation and Alzheimer's disease-relevant changes in microglial and neuronal cells.

Authors:  Heather M Wilkins; Steven M Carl; Sam G Weber; Suruchi A Ramanujan; Barry W Festoff; Daniel A Linseman; Russell H Swerdlow
Journal:  J Alzheimers Dis       Date:  2015       Impact factor: 4.472

4.  Cutting edge: TREM-2 attenuates macrophage activation.

Authors:  Isaiah R Turnbull; Susan Gilfillan; Marina Cella; Taiki Aoshi; Mark Miller; Laura Piccio; Maristela Hernandez; Marco Colonna
Journal:  J Immunol       Date:  2006-09-15       Impact factor: 5.422

Review 5.  Transcriptional regulation of Alzheimer's disease genes: implications for susceptibility.

Authors:  J Theuns; C Van Broeckhoven
Journal:  Hum Mol Genet       Date:  2000-10       Impact factor: 6.150

6.  Altered metabolism of the amyloid beta precursor protein is associated with mitochondrial dysfunction in Down's syndrome.

Authors:  Jorge Busciglio; Alejandra Pelsman; Caine Wong; Gustavo Pigino; Menglan Yuan; Hiroshi Mori; Bruce A Yankner
Journal:  Neuron       Date:  2002-02-28       Impact factor: 17.173

7.  TREM2 lipid sensing sustains the microglial response in an Alzheimer's disease model.

Authors:  Yaming Wang; Marina Cella; Kaitlin Mallinson; Jason D Ulrich; Katherine L Young; Michelle L Robinette; Susan Gilfillan; Gokul M Krishnan; Shwetha Sudhakar; Bernd H Zinselmeyer; David M Holtzman; John R Cirrito; Marco Colonna
Journal:  Cell       Date:  2015-02-26       Impact factor: 41.582

8.  TREM2 variants in Alzheimer's disease.

Authors:  Rita Guerreiro; Aleksandra Wojtas; Jose Bras; Minerva Carrasquillo; Ekaterina Rogaeva; Elisa Majounie; Carlos Cruchaga; Celeste Sassi; John S K Kauwe; Steven Younkin; Lilinaz Hazrati; John Collinge; Jennifer Pocock; Tammaryn Lashley; Julie Williams; Jean-Charles Lambert; Philippe Amouyel; Alison Goate; Rosa Rademakers; Kevin Morgan; John Powell; Peter St George-Hyslop; Andrew Singleton; John Hardy
Journal:  N Engl J Med       Date:  2012-11-14       Impact factor: 91.245

9.  Microglia regulate hippocampal neurogenesis during chronic neurodegeneration.

Authors:  Chiara De Lucia; Adeline Rinchon; Adrian Olmos-Alonso; Kristoffer Riecken; Boris Fehse; Delphine Boche; V Hugh Perry; Diego Gomez-Nicola
Journal:  Brain Behav Immun       Date:  2015-11-02       Impact factor: 7.217

10.  Autocrine CSF-1R signaling drives mesothelioma chemoresistance via AKT activation.

Authors:  M Cioce; C Canino; C Goparaju; H Yang; M Carbone; H I Pass
Journal:  Cell Death Dis       Date:  2014-04-10       Impact factor: 8.469

View more
  12 in total

1.  HIV-1 TAT-mediated microglial activation: role of mitochondrial dysfunction and defective mitophagy.

Authors:  Annadurai Thangaraj; Palsamy Periyasamy; Ke Liao; Venkata Sunil Bendi; Shannon Callen; Gurudutt Pendyala; Shilpa Buch
Journal:  Autophagy       Date:  2018-07-26       Impact factor: 16.016

2.  Modulation of OSCP mitigates mitochondrial and synaptic deficits in a mouse model of Alzheimer's pathology.

Authors:  Esha Gauba; Shaomei Sui; Jing Tian; Christopher Driskill; Kun Jia; Chunxiao Yu; Tripta Rughwani; Qi Wang; Sven Kroener; Lan Guo; Heng Du
Journal:  Neurobiol Aging       Date:  2020-10-16       Impact factor: 4.673

Review 3.  Molecular and phenotypic biomarkers of aging.

Authors:  Xian Xia; Weiyang Chen; Joseph McDermott; Jing-Dong Jackie Han
Journal:  F1000Res       Date:  2017-06-09

Review 4.  Mitochondria-Derived Damage-Associated Molecular Patterns in Neurodegeneration.

Authors:  Heather M Wilkins; Ian W Weidling; Yan Ji; Russell H Swerdlow
Journal:  Front Immunol       Date:  2017-04-26       Impact factor: 7.561

5.  Circulating cell-free mitochondrial DNA levels in Parkinson's disease are influenced by treatment.

Authors:  Hannah Lowes; Angela Pyle; Mauro Santibanez-Koref; Gavin Hudson
Journal:  Mol Neurodegener       Date:  2020-02-18       Impact factor: 14.195

6.  Emerging perspectives on mitochondrial dysfunction and inflammation in Alzheimer's disease.

Authors:  Seung-Min Yoo; Jisu Park; Seo-Hyun Kim; Yong-Keun Jung
Journal:  BMB Rep       Date:  2020-01       Impact factor: 4.778

7.  Post-mortem ventricular cerebrospinal fluid cell-free-mtDNA in neurodegenerative disease.

Authors:  Hannah Lowes; Marzena Kurzawa-Akanbi; Angela Pyle; Gavin Hudson
Journal:  Sci Rep       Date:  2020-09-17       Impact factor: 4.379

Review 8.  Targeting whole body metabolism and mitochondrial bioenergetics in the drug development for Alzheimer's disease.

Authors:  Steven N Austad; Scott Ballinger; Thomas W Buford; Christy S Carter; Daniel L Smith; Victor Darley-Usmar; Jianhua Zhang
Journal:  Acta Pharm Sin B       Date:  2021-06-30       Impact factor: 11.413

Review 9.  The Microbiome-Mitochondria Dance in Prodromal Parkinson's Disease.

Authors:  Sandra M Cardoso; Nuno Empadinhas
Journal:  Front Physiol       Date:  2018-05-09       Impact factor: 4.566

Review 10.  Contribution of Mitochondrial Dysfunction Combined with NLRP3 Inflammasome Activation in Selected Neurodegenerative Diseases.

Authors:  Anna Litwiniuk; Agnieszka Baranowska-Bik; Anita Domańska; Małgorzata Kalisz; Wojciech Bik
Journal:  Pharmaceuticals (Basel)       Date:  2021-11-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.